Drawing for SUPRAPRP

USPTO serial 87269712

SUPRAPRP

Reviewed by CopyMark Law Group

Reg. 5984748Status 702Registered
Filing date
Status date
Registration date
Feb 11, 2020
Examiner
CIURPITA, DREW PETER FISHER
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with SUPRAPRP?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Susan N. Acquista, Esq.

Susan N. Acquista, Esq. DLA Piper LLP (US)4365 Executive Drive, Suite 1100San Diego, CA 92121United States

Goods and services

ClassDescriptionStatusFirst use
005Medical preparations, namely, solutions containing platelet rich plasma derived from donors pre-treated with G-CSF such that said preparations contain, in addition to platelets, mesenchymal and other stem and progenitor cells, for use on, in, or under tissue, bone and organs for the purpose of promoting cellular regeneration, tissue adhesion, wound healing, bone and periodontum growth and bone, organ or tissue regenerationACTIVEApr 27, 2015
010Kits comprising at least one receptacle for receipt and separation of blood components from each other used to prepare platelet rich plasma, derived from donors pre-treated with g-csf, such that said platelet rich plasma features mesenchymal and other stem and progenitor cells in addition to plateletsACTIVEApr 27, 2015
035Marketing services in the nature of marketing and business support services for physicians who provide clinical medical practice consultation services in the field of advanced regenerative technologies featuring provision of preparations or services comprising application on, in, or under tissue, bone or organs of platelet rich plasma derived from donors pre-treated with G-CSF such that said preparations contain, in addition to platelets, mesenchymal and other stem and progenitor cells, for the purpose of promoting cellular regeneration, tissue adhesion, wound healing, bone or periodontal growth and bone organ or tissue regenerationACTIVEApr 8, 2019
041Educational services, namely, providing clinical training in the field of advanced regenerative technologies, namely, training for physicians to perform clinical services in the field of advanced regenerative technologies; providing training to prepare and provide preparations or services comprising application on, in, or under tissue, bone or organs of platelet rich plasma derived from donors pre-treated with G-CSF such that said preparations contain, in addition to platelets, mesenchymal and other stem and progenitor cells, for the purpose of promoting cellular regeneration, tissue adhesion, wound healing, bone or periodontal growth and bone organ or tissue regenerationACTIVEApr 8, 2019
044Medical, veterinary, hygienic and beauty care services for human beings or animals, namely, the preparation, provision or both in or under tissue, bone or organs, of platelet rich plasma derived from donors pre-treated with G-CSF such that said preparations contain, in addition to platelets, mesenchymal and other stem and progenitor cells, for the purpose of promoting cellular regeneration, tissue adhesion, wound healing, bone or periodontal growth and bone organ or tissue regenerationACTIVEApr 8, 2019

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 23, 2026NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Mar 23, 2026C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Mar 23, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Dec 24, 2025E815TEAS SECTION 8 & 15 RECEIVED—
Feb 11, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jan 4, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jan 4, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 4, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 4, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 4, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Feb 11, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 4, 2020SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jan 3, 2020CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Dec 14, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 13, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 13, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 13, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 13, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 13, 2019CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 31, 2019DOCKASSIGNED TO EXAMINER—
Apr 24, 2019SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Apr 24, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Apr 12, 2019IUAFUSE AMENDMENT FILED—
Apr 12, 2019EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Mar 28, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 28, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 30, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 4, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 4, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 15, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 30, 2018PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jul 20, 2018ALIEASSIGNED TO LIE—
Jul 19, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 6, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Jul 6, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 6, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 6, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 19, 2018ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
May 15, 2018PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Apr 27, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 19, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 19, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 19, 2018ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Apr 19, 2018GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Apr 19, 2018GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 19, 2018CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 7, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 7, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 28, 2018ALIEASSIGNED TO LIE—
Feb 19, 2018NREVNOTICE OF REVIVAL - E-MAILED—
Feb 18, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 18, 2018PETGPETITION TO REVIVE-GRANTED—
Feb 18, 2018PROATEAS PETITION TO REVIVE RECEIVED—
Feb 18, 2018TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 9, 2018MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Feb 9, 2018ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jul 12, 2017GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Jul 12, 2017GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Jul 12, 2017CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Apr 7, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 7, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 7, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 31, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 31, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 31, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 17, 2017DOCKASSIGNED TO EXAMINER—
Dec 21, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 19, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance